Table VI.
Factors | Recurrence-free survival
|
Cancer-specific survival
|
||||
---|---|---|---|---|---|---|
Univariate
|
Multivariate
|
Univariate
|
Multivariate
|
|||
P-value | HR (95% CI) | P-value | P-value | HR (95% CI) | P-value | |
Age (years) | 0.2070 | 0.0325 | 0.2167 | |||
≤62 | ||||||
>62 | 3.45 (0.52–67.8) | |||||
Sex | 0.6169 | 0.5200 | ||||
Female | ||||||
Male | ||||||
pT stage | <0.0001 | 0.0582 | 0.0283 | 0.1785 | ||
≤pT2 | ||||||
≥pT3 | 3.06 (0.96–9.55) | 0.23 (0.02–1.94) | ||||
Fuhrman grade 2 | 0.0300 | 0.7038 | 0.0007 | 0.0389 | ||
Non-upgraded group | ||||||
Upgraded group | 1.19 (0.49–2.88) | 7.20 (1.09–143) | ||||
TN | <0.0001 | 0.0349 | <0.0001 | 0.0444 | ||
Absence | ||||||
Presence | 3.33 (1.09–9.75) | 7.58 (1.06–47.2) | ||||
MVI | <0.0001 | 0.0047 | 0.0001 | 0.0168 | ||
Absence | ||||||
Presence | 4.65 (1.63–12.8) | 9.48 (1.54–74.1) |
ccRCC, clear cell renal cell carcinoma; TN, tumor necrosis; MVI, microvascular invasion; HR, hazard ratio; CI, confidence interval.